Table 4 Subject of the methods issued to conduct and/or report a systematic review by each study
From: Recommendations to conduct and report systematic reviews in medical literature: a scoping review
Subject of methods | N (%) |
|---|---|
Any | 33 (39.8%) |
Any, Adverse effects, Economic evidence, Qualitative research, Public health, and health promotion¥ | 1 (1.2%) |
Any, Diagnostic tests, Prognostic tests, Public health interventions, Adverse Effects, Economic evaluations, Qualitative evidence¥ | 1 (1.2%) |
Any, Qualitative evidence, Quantitative evidence, Economic evidence, Textual and non-research evidence, Text and opinion data¥ | 1 (1.2%) |
Clinical Subject | 20 (24.0%) |
Cardiology | 4 (4.8%) |
Pain | 2 (2.4%) |
Nephrology | 2 (2.4%) |
Sports medicine and orthopedic surgery | 2 (2.4%) |
Geriatric | 1 (1.2%) |
Neck and back pain, and related spinal disorders | 1 (1.2%) |
Nutrition | 1 (1.2%) |
Ophthalmology | 1 (1.2%) |
Pathology | 1 (1.2%) |
Plastic and Reconstructive Surgery | 1 (1.2%) |
Pregnancy and childcare | 1 (1.2%) |
Radiology | 1 (1.2%) |
Tuberculosis | 1 (1.2%) |
Urology | 1 (1.2%) |
Investigation procedures subject | 11 (13.2%) |
Diagnostic test | 5 (6.0%) |
Diagnostic test and prognostic test | 2 (2.4%) |
Medical tests, genetic tests, and prognostic tests | 1 (1.2%) |
Radiography | 1 (1.2%) |
Surgical procedures | 1 (1.2%) |
Toxicology | 1 (1.2%) |
Other healthcare interventions | 8 (9.6%) |
Rehabilitation | 3 (3.6%) |
Nursing practice | 2 (2.4%) |
Pediatric practice nursing | 1 (1.2%) |
Physiotherapy | 1 (1.2%) |
Occupational therapy | 1 (1.2%) |
Others | 8 (9.6%) |
Economic | 2 (2.4%) |
Harms | 2 (2.4%) |
Anatomy | 1 (1.2%) |
Complex multi-component health care interventions | 1 (1.2%) |
Patient-reported outcome measures | 1 (1.2%) |
Prediction model performance | 1 (1.2%) |
Total | 83 (100%) |